Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
36.07
+0.81 (2.30%)
At close: Aug 13, 2025, 4:00 PM
35.50
-0.57 (-1.58%)
After-hours: Aug 13, 2025, 7:55 PM EDT
Revolution Medicines Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$69.42
Upside
+92.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $57 → $56 | Strong Buy | Maintains | $57 → $56 | +55.25% | Aug 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +80.21% | Jul 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +121.79% | Jun 25, 2025 |
| Needham | Needham | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +58.03% | Jun 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $73 → $72 | Strong Buy | Maintains | $73 → $72 | +99.61% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $70 → $75 | Buy | Maintains | $70 → $75 | +107.93% | May 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $87 → $80 | Strong Buy | Maintains | $87 → $80 | +121.79% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +58.03% | May 8, 2025 |
| Wedbush | Wedbush | Buy Reiterates $67 | Buy | Reiterates | $67 | +85.75% | Apr 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $59 | Strong Buy | Reiterates | $59 | +63.57% | Apr 8, 2025 |
| Stifel | Stifel | Strong Buy Maintains $78 → $64 | Strong Buy | Maintains | $78 → $64 | +77.43% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $73 | Strong Buy | Maintains | $72 → $73 | +102.38% | Mar 3, 2025 |
| Stifel | Stifel | Strong Buy Maintains $80 → $78 | Strong Buy | Maintains | $80 → $78 | +116.25% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Maintains $60 → $59 | Strong Buy | Maintains | $60 → $59 | +63.57% | Feb 27, 2025 |
| UBS | UBS | Strong Buy Maintains $65 → $71 | Strong Buy | Maintains | $65 → $71 | +96.84% | Jan 8, 2025 |
| Wedbush | Wedbush | Buy Maintains $70 → $67 | Buy | Maintains | $70 → $67 | +85.75% | Dec 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.